Monsanto First-Quarter Profit Up on South America Strength

Monsanto Co. reported higher earnings in the first quarter than the prior year on strong demand from its South American business.

Net income was $29 million in the first quarter, reversing a $253 million loss in the year-ago period. Total crop protection, or Agricultural Productivity, sales dropped to $802 million from $820 million in the prior-year quarter. Seeds and Genomics sales were stronger, climbing to $1.8 billion from $1.4 billion.

“We’ve been very pleased with the strong support — especially from shareowners and growers — for the agreement to combine with Bayer,” said Hugh Grant, chairman and chief executive officer. “We expect the combination with Bayer to amplify the rate of innovation faster than either company could achieve alone, which will be critical in helping to increase grower productivity to meet projected demand in the decades ahead.”

With the expected strong start in the first quarter and continued focus on return on innovation and financial discipline, the company remains confident in its fiscal year 2017 outlook. Despite the fact that the year-over-year change in currency rates was modestly favorable in the first quarter of fiscal year 2017, the company continues to assume that the change in rates will have a relatively neutral effect on a full year basis given the recent strengthening of the U.S. dollar against several currencies.

The fiscal year 2017 full-year as-reported EPS guidance is expected to be in the range of $3.97 to $4.45. These earnings are expected to translate into $2.4-to-$2.8 billion of operating cash flows and $1.4-to-$1.6 billion of free cash flows, after deducting an estimated $1.0-to-$1.2 billion of investing cash flows. These investing cash flows reflect the planned investment in the company’s dicamba manufacturing facility and assume the successful sale of the precision agriculture equipment business.

The company expects roughly $100 million of gross profit from strategic licensing deals towards the end of the fiscal year which is anticipated to be roughly split between Seeds and Genomics and Ag Productivity. Seeds and Genomics segment gross profit is expected to increase to mid-single digits as a percent year-over-year, with soybean gross profit alone expected to grow by more than 20 percent, driven by new trait penetration and an anticipated reduction in cost of goods sold. In corn, growth is expected to come from global genetic share gains and global germplasm price mix lift in local currency that is flat to up low-single-digits, in terms of percentages. The company expects global corn acres to be roughly flat, with declines in U.S. corn acreage offset by the early increases in South America.

The company adjusted Ag Productivity gross profit to the expected range of $850-to-$950 million, reflecting year-over-year price declines in glyphosate-based herbicides in the first half of the year, offset partially by the benefit of licensing opportunities and expected higher volumes. The adjustment in gross profit outlook is a result of the approximately $85 million benefit from the sale of the Latitude wheat fungicide business that was ultimately recorded in other expense, net for the segment, as opposed to gross profit as anticipated.

The company’s restructuring and cost savings initiatives remain on track, with the opportunity to deliver approximately $380 million in annual savings at the close of fiscal 2017 in operating expenses and cost of good sold, as compared to fiscal year 2015. However, setting aside pending Bayer transaction related costs and restructuring expenses, overall operating expenses in fiscal 2017 are expected to increase slightly with inflation and the costs associated with the return to growth of the business more than offsetting the savings. The expected tax rate for the year remains in the range of 25-to-28 percent.

For the second quarter of fiscal year 2017, the company expects as-reported and ongoing earnings per share that is approximately $0.20 to $0.50 better than the prior year. The company sees this first half earnings improvement as a reflection of the benefit from the sale of the Latitude business and the absence of a significant portion of the Argentine peso devaluation from the prior year. In the second half of the fiscal year, the company expects roughly 40 cents less in earnings per share benefit from strategic deals versus the prior year in addition to a more challenging currency environment than in the first quarter.

The company’s higher Seeds and Genomics sales in the first quarter included a 25-plus percent increase in planted corn acres in Argentina and more than a 10 percent increase in corn acres planted in Brazil accompanied by double-digit price increases in corn germplasm in local currency in both countries. In the U.S., demand for year-one hybrids remains strong and the early read on the order book supports the company’s intention to grow genetic share.

The company continues to build on the momentum of Intacta RR2 PRO soybeans in South America as it remains on track to reach a target of 45 to 55 million acres in fiscal year 2017. In the U.S., demand for Roundup Ready 2 Xtendsoybeans remains strong and the company is well-supplied for more than 15 million acres of the product. With the EPA approval for in-crop use of dicamba in-hand, the company has received nearly two-thirds of the necessary state approvals for both soybeans and cotton, and expects to have the rest before planting. The company said it has provided extensive, ongoing customer training and expects customers will have an outstanding experience with the Roundup Ready® Xtend crop system.

Topics: , , ,

Agrichemicals

Agrichemicals

Brazil Suspends 63 Fungicides Targeting Asian Soybean Rust

Resistance of the fungus to fungicides has spread widely in the country.

Africa/Middle East

Farmers Scrutinize Costs as Acreage for Major Crops Decreases

The total planting area of eight staple crops in the United States will decline almost annually through 2026, with acreage

Agrichemicals

Syngenta CEO Expects Merger Regulatory Approval Soon – Reuters

Syngenta Chief Executive Erik Fyrwald expects regulatory approval soon for ChemChina’s proposed $43 billion takeover of the Swiss pesticides and

Agrichemicals

Embrapa, Bayer to Map Mechanism of Soybean Disease Resistance to Fungicides

The Brazilian Agricultural Research Corporation (Embrapa) and Bayer have established a partnership to study the mechanisms that cause soybean pathogenic

Agrichemicals

Jiangxi Heyi to Acquire Stake in Changlong Chemicals

Changlong Chemical’s net assets valuation reached 372 million yuan as of By Dec. 31, 2016, Dec. 31, 2016.

Agrichemicals

Monsanto Unveils 2017 Updates on R&D Pipeline

R&D Showcase focuses on reducing inputs, improving grower productivity and identifying ways to mitigate environmental challenges.

Agrichemicals

Arysta LifeScience Introduces Seed Treatment for Soybeans

RANCONA V 100 PRO combines two fungicides that provide both contact and systemic activity against a broad spectrum of diseases.

Agrichemicals

CAC Continues to Expand

Q How will this show compare to last year’s show in terms of exhibitors and attendees? 18th China International Agrochemical

Africa/Middle East

Regulatory Predictability Needed for an Industry Committed to Innovation

The crop protection industry helps millions of farmers grow their crops every year. From Asia to Africa and from Europe

Flag of China
Agrichemicals

Chinese CP Market Saw Negative Growth in 2016 — Where Is the Market Headed?

For the first time in years the Chinese crop protection (CP) market is expected to experience negative growth in 2016.

Agrichemicals

The Path Ahead for M&A

Divestitures following a year of super mergers are around the corner. Know what to expect next, straight from the experts.

Flag of China
Agrichemicals

Glyphosate Price in China Likely to Continue Rising

After a long period of declining glyphosate prices in China, the current season is strengthening confidence for a rebound. The

Agrichemicals

FMC Assumes Full Ownership of FMC Suzhou Crop Care in China

FMC Corp. announced it has taken full ownership of the joint-venture operations of FMC (Suzhou) Crop Care Co., Ltd. (FMS)

Agrichemicals

Facing 2017 with a Smaller Insect-Fighting Arsenal

There’s no way around it: Loss is a central theme this year in dealing with insect pressure in the U.S.

Agrichemicals

Monsanto Shareholders Approve Bayer Merger

Monsanto Company announced that at a special meeting of shareowners held today, shareowners of the company approved the merger of

Agrichemicals

Syngenta’s Talinor Herbicide Receives EPA Approval

Syngenta announced it received Environmental Protection Agency for its Talinor herbicide for control of broadleaf weeds in wheat and barley.

Agrichemicals

DuPont Gets Registration for Luminesa Seed Treatment

DuPont recently received registration approval from the Environmental Protection Agency for  Lumisena fungicide seed treatment. Lumisena fungicide seed treatment improves

Agrichemicals

Syngenta Gets Registration for Fungicide Premix

Syngenta announced that Orondis Opti fungicide premix is now registered and approved for use on specialty and vegetable crops by

Agrichemicals

Proxy Advisory Firms Recommend Shareholders Vote For Monsanto-Bayer Merger

Monsanto Company announced that leading independent proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC

Latest News

Industry News

USDA Invests $13.6 Million in Citrus Greening Research

The U.S. Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) announced four grants totaling more than $13.6

Americas

Bayer, MS Technologies Get China Approval for Balance GT Soybeans

MS Technologies and Bayer have received import approval from China for Balance GT soybeans. The new Balance GT Soybean Performance System will

Agrichemicals

Brazil Suspends 63 Fungicides Targeting Asian Soybean Rust

Resistance of the fungus to fungicides has spread widely in the country.

Africa/Middle East

Farmers Scrutinize Costs as Acreage for Major Crops Decreases

The total planting area of eight staple crops in the United States will decline almost annually through 2026, with acreage

Agrichemicals

Syngenta CEO Expects Merger Regulatory Approval Soon – Reuters

Syngenta Chief Executive Erik Fyrwald expects regulatory approval soon for ChemChina’s proposed $43 billion takeover of the Swiss pesticides and